Toronto

Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

admin April 28, 2025

<div class="image-wrapper yf-g633g8 small" style="--img-width: 300px; --img-height:...

University of Toronto – Breakthrough Prize recognizes Daniel Drucker for work leading to diabetes, anti-obesity drugs

University of Toronto – Breakthrough Prize recognizes Daniel Drucker for work leading to diabetes, anti-obesity drugs

admin April 11, 2025

Daniel Drucker, the Canadian scientist renowned for discoveries that sparked the advent of Ozempic...

Toronto Public Health says more patients of gynecologist under investigation can now get tested

Toronto Public Health says more patients of gynecologist under investigation can now get tested

admin March 20, 2025

Toronto Public Health says more patients of a gynecologist linked to potential exposure...